Watch for Cabenuva, a New Monthly Injectable for HIV

March 2021

Cabenuva (cabotegravir/rilpivirine) will be the first MONTHLY injectable treatment for adults living with HIV.

Cabenuva comes in a kit containing one vial of cabotegravir and one vial of rilpivirine. For a dose, each med is injected into the buttock (gluteal) muscle by a clinician.

Be aware that it's a specialty med that costs about $4,000/month.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

COVID-19 Prevent Pitfalls With Vaccines and Treatments for COVID-19
Communication Don't Shy Away From Communicating Concerns to Colleagues
COVID-19 Be Familiar With the New Viral Vector Vaccine for COVID-19
Injectables Use Strategies to Ensure Safety With IM Meds
COVID-19 Don't Be Surprised to See Additional Meds Used for COVID-19
Pediatrics Avoid Mishaps When Dispensing Meds for "NOWS"
HIV & AIDS Watch for Cabenuva, a New Monthly Injectable for HIV
Immunizations Reduce the Risk of Pain or Injury From IM Vaccinations
Overactive Bladder Think of Gemtesa as Similar to Myrbetriq for Overactive Bladder

Watch for Cabenuva, a New Monthly Injectable for HIV

Practical advice for a better career, with unlimited access to CE

Table of Contents